Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Methyl 3,4-dihydroxybenzoate
Cat. No.:
0225LY-1445
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR, and HPLC.
Size:
Add to basket
Product Overview
Description:
Methyl 3,4-dihydroxybenzoate is a primary green tea metabolite with strong anti-inflammatory and antioxidant activities.
Synonym:
3,4-Dihydroxybenzoic acid methyl ester; Methyl protocatechuate; Protocatechuic acid methyl ester; 2150-43-8; Methyl protocatechuate; 3,4-Dihydroxybenzoic acid methyl ester; Protocatechuic acid, methyl ester; Benzoic acid, 3,4-dihydroxy-, methyl ester; MDHB; Methyl 3,4-bis(oxidanyl)benzoate
CAS No.:
2150-43-8
Compound CID:
287064
Formula:
C8H8O4
Formula Weight:
168.15
Specification
Relative Density:
1.354 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Methyl 3,4-dihydroxybenzoate can be used in biochemical studies to explore its role in stimulating collagen synthesis or its antioxidant activities.
Library Information
Target:
Nrf2
Receptor:
Keap1-Nrf2
Pathways:
Immunology/Inflammation; Oxidation-reduction; Apoptosis
Plate Number:
AOCL-19
Plate Location:
e8
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10mM DMSO
DMSO Max Solubility:
30 mg/mL; 178.41 mM
